CIK 0001599298 · Large accelerated filer
Summit Therapeutics Inc.
Sign in to watch- Ticker
- SMMT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 371979717
- Phone
- 305-203-2034
- Business address
- 601 BRICKELL KEY DRIVE, SUITE 1000, MIAMI, FL, 33131
- Former names
- Summit Therapeutics plc, Summit Corp plc
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 8 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-04-25 | Gayko Urte Director | Grant or award · Stock Option (right to buy) | +400,000 | 400,000 | ||
| 2022-01-03 | Gayko Urte Director | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2022-01-03 | Gayko Urte Director | Grant or award · Stock Option (right to buy) | +42,553 | $1.13 | $48K | 67,553 |
| 2022-01-03 | Mahatme Ujwala Director | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2022-01-03 | Mahatme Ujwala Director | Grant or award · Stock Option (right to buy) | +47,872 | $1.13 | $54K | 72,872 |
| 2022-01-03 | Soni Manmeet Singh Director | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2022-01-03 | Soni Manmeet Singh Director | Grant or award · Stock Option (right to buy) | +82,446 | $1.13 | $93K | 107,446 |
| 2022-01-03 | Clark Kenneth A Director | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2022-01-03 | Clark Kenneth A Director | Grant or award · Stock Option (right to buy) | +58,510 | $1.13 | $66K | 83,510 |
| 2021-12-15 | Maranian Jeffrey R VP Corporate Controller | Grant or award · Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2021-12-15 | Zanganeh Maky Chief Operating Officer | Grant or award · Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2021-11-11 | Maranian Jeffrey R VP Corporate Controller | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2021-11-03 | Gayko Urte Director | Grant or award · Stock Option (right to buy) | +200,000 | 200,000 | ||
| 2021-11-03 | Gayko Urte Director | Grant or award · Stock Option (right to buy) | +4,041 | 204,041 | ||
| 2021-10-07 | Clark Kenneth A Director | Grant or award · Stock Option (right to buy) | +200,000 | 200,000 | ||
| 2021-10-07 | Clark Kenneth A Director | Grant or award · Stock Option (right to buy) | +6,250 | 206,250 | ||
| 2021-05-12 | DUGGAN ROBERT W Chief Executive Officer | Purchase | +11,365,921 | $5.24 | $59.6M | 67,662,454 |
| 2021-05-12 | Zanganeh Maky Chief Operating Officer | Purchase | +389,077 | $5.24 | $2.0M | 2,643,319 |
| 2021-02-28 | Wang Luhua Director | Grant or award · Stock Option (right to buy) | +21,096 | $6.77 | $143K | 91,096 |
| 2021-02-26 | Wang Luhua Director | Grant or award · Stock Option (right to buy) | +70,000 | $6.77 | $474K | 70,000 |
Page 8 of 9 · 163 trades